A stalled Brexit, potential rapprochement between the two Koreas and the fastest marathon time ever recorded.
If you were going to die, should you have the right to try experimental drugs that might save your life?
While some supporters want terminal patients to have access to any treatment that might help them, critics worry that unproven treatments might unfairly raise hopes for miracles.
- Sarah Karlin-Smith Health care reporter, Politico; @SarahKarlin
- Alison Bateman-House Co-chair of the NYU Langone Health Working Group on Compassionate Use and Pre-Approval Access. Assistant Professor in the Division of Medical Ethics at New York University Langone Medical Center. @ABatemanHouse
- Robert Graboyes Senior Research Fellow and Health Care Scholar at the Mercatus Center at George Mason University. @Robert_Graboyes
- Dr. Kelly Shanahan Medical director of METUp, a patient advocacy group for those with metastatic cancer. Former OB/GYN, currently living with Stage IV breast cancer. @stage4kelly
- Michael Becker President and founder of MDB Communications LLC. Author of "A Walk with Purpose," about his time as a biotechnology executive and his Stage IV head & neck cancer diagnosis. @Becker_MichaelD
Most Recent Shows
As Supreme Court nominee Brett Kavanaugh faces an accusation of sexual assault, several high profile men who lost their jobs for sexual misconduct are staging comebacks. What does all this say about the impact of the #MeToo movement?
More than 70 percent of LGBTQ youth report feelings of worthlessness and hopelessness in the past week.
Once the hub of steel production, Pittsburgh is now a hotspot for another burgeoning industry: artificial intelligence.